Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1
Research shows that in senescent cells, p53 levels are maintained low through ubiquitination while its pro-apoptotic activity is repressed through nuclear segregation by FOXO4. The peptide's competitive inhibition restores p53 activity by promoting nuclear exclusion, allowing p53 to execute its pro-apoptotic program and eliminate senescent cells through targeted pathway activation
Mudhol, Shujalpur, Mandvi, Thangadh, Sironj, Nandura, Shoranur, Nathdwara, Periyakulam, Sultanganj, Medak, Narayanpet, Raxaul Bazar Rajauri, Pernampattu, Nainital, Ramachandrapuram, Vaijapur, Nangal, Sidlaghatta, Punch, Pandhurna, Wadgaon Road, Talcher, Varkala, Pilani, Nowgong, Naila Janjgir, Mapusa
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
The review highlights its pleiotropic beneficial effects in tissue injury, inflammatory bowel disease, and CNS disorders, and concludes that BPC-157 demonstrates a favorable safety profile with few reported side effects, positioning it as a candidate for further clinical investigation
Axotomy of the peripheral nerve leads to a rapid decline in muscle mass, which can be reversible if there is good quality muscle re-innervation